• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconSinopharm

Sinopharm

The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
FinanceThe world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By Paige McGlauflinAugust 15, 2022
A Sinopharm booster generates ‘significantly lower’ levels of antibodies against Omicron, according to a new study
HealthA Sinopharm booster generates ‘significantly lower’ levels of antibodies against Omicron, according to a new study
By Chris Kay and BloombergDecember 20, 2021
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
HealthJ&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021
Pfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs
HealthPfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs
By Jason Gale and BloombergNovember 15, 2021
CTW 2021-01-Vaccine Makers
MagazineCOVID-19 vaccine makers fight the pandemic fight, worldwide
By David MeyerOctober 11, 2021
How do China’s COVID vaccines fare against the Delta variant?
How do China’s COVID vaccines fare against the Delta variant?
By Grady McGregorAugust 31, 2021
Countries eye booster shots as the delta variant evades less effective COVID vaccines
HealthCountries eye booster shots as the delta variant evades less effective COVID vaccines
By BloombergJuly 10, 2021
6 fully vaccinated people have died from COVID-19 in one of the world’s most-vaccinated countries
Health6 fully vaccinated people have died from COVID-19 in one of the world’s most-vaccinated countries
By Vidya Gappy, Antony Sguazzin and BloombergJuly 2, 2021
China is filling the global COVID vaccine shortage left by the U.S. and India
HealthChina is filling the global COVID vaccine shortage left by the U.S. and India
By Iain Marlow, Sudhi Ranjan Sen, James Paton and BloombergMay 7, 2021
A view of Biological Security Research Institute where 50.000 doses of Kazakhstan's homegrown coronavirus vaccine QazVac produced in Jambyl region, Kazakhstan on April 22, 2021.
HealthA new vaccine on the scene: Kazakhstan begins rollout of homegrown QazVac
By David MeyerApril 26, 2021
A Chinese drugmaker says its COVID-19 vaccine candidate is 79% effective
HealthA Chinese drugmaker says its COVID-19 vaccine candidate is 79% effective
By Naomi Xu ElegantDecember 30, 2020
A Chinese vaccine maker says it’s inoculated 1 million people—even though its trials are incomplete
HealthA Chinese vaccine maker says it’s inoculated 1 million people—even though its trials are incomplete
By Grady McGregorNovember 20, 2020
1
  • 1
1
Most Popular
Innovation
Google CEO Sundar Pichai says we’re just a decade away from a new normal of extraterrestrial data centersplaceholder alt text
By Fortune EditorsApril 3, 2026
North America
The World Cup is supposed to be an economic windfall. But 'you're seeing a number of headwinds' nowplaceholder alt text
By Fortune EditorsApril 4, 2026
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Fortune EditorsApril 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.